After discovering that amyloid-β triggers NLRP3 signaling in vitro, Heneka et al. provided evidence suggesting that the NLRP3 inflammasome is crucial in driving Alzheimer’s disease in vivo [34]. The gene discussed is NLRP3; the disease is Alzheimer disease.